Bowel (colorectal) cancer, Colon cancer, Rectal cancer, Secondary cancers
Results
Phase 1/2
This trial looked at a drug called AZD8931 and chemotherapy for bowel cancer.
Cancer Research UK supported this trial.
This trial was open for people to join between 2014 and 2017. The team published the results in 2022.
Recruitment start: 6 May 2014
Recruitment end: 9 June 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Daniel Hochhauser
AstraZeneca
Cancer Research UK
CRUK & UCL Cancer Trials Centre
Experimental Cancer Medicine Centre (ECMC)
NIHR University College London Hospitals Biomedical Research Centre
University College London (UCL)
This is Cancer Research UK trial number CRUKD/12/015.
Last reviewed: 24 February 2023
CRUK internal database number: 10381